Nektar Therapeutics NKTR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.9M-24.5% | -$36.08M-1.6% | -$35.52M+14.6% | -$41.59M+18.3% | -$50.88M— | ||
| $151K-20.5% | $190K-3.1% | $196K-8.4% | $214K-49.8% | $426K+28.3% | ||
| $3.36M+53.0% | $2.19M-28.6% | $3.07M-11.9% | $3.49M-10.6% | $3.9M-18.8% | ||
| -$44.3M+31.8% | -$64.96M-33.2% | -$48.76M-6.6% | -$45.74M+6.8% | -$49.05M-6.2% | ||
| $18K0.0% | $18K-84.2% | $114K+208% | $37K+1,750% | $2K-99.6% | ||
| -$350.79M— | —— | -$94.87M-291% | $49.62M+13.6% | $43.69M-27.4% | ||
| $529.55M+1,269% | $38.67M-72.7% | $141.68M+67,045% | $211K+2,914% | $7K-91.6% | ||
| $134.46M+619% | -$25.92M-1,225% | -$1.96M— | —— | -$5.36M-138% | ||
| -$44.32M+31.8% | -$64.98M-32.9% | -$48.88M-6.8% | -$45.78M+6.7% | -$49.06M-5.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nektar Therapeutics generate?
- Nektar Therapeutics (NKTR) generated -$203.8M in operating cash flow over the trailing twelve months.
- What is Nektar Therapeutics's free cash flow?
- After $187.0K of capital expenditures, Nektar Therapeutics's free cash flow was -$203.9M over the trailing twelve months, down 14.4% year over year.
- Where does Nektar Therapeutics's cash flow data come from?
- Every line is extracted from Nektar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
